Putnam Investments LLC Castle Biosciences Inc Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Putnam Investments LLC holds 25,006 shares of CSTL stock, worth $844,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,006
Previous 25,795
3.06%
Holding current value
$844,702
Previous $435,000
23.91%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CSTL
# of Institutions
183Shares Held
26.1MCall Options Held
511KPut Options Held
100-
Black Rock Inc. New York, NY3.04MShares$103 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$78.6 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$53.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$52 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$41.1 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $888M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...